Allergan to accept shareholder proposal to split CEO, chairman roles

After facing pressure from hedge fund Appaloosa LP to separate the roles of chairman and CEO, Allergan announced its intent to do so.

Allergan said it would support a shareholder proposal that will require "an independent board chair to be phased in during the next leadership transition."

The announcement "reflects our board's ongoing commitment to active board refreshment and governance best practices, as well as continuous engagement with our shareholders," said Chris Coughlin, the lead independent director of Allergan's board.

No further details about the proposal were disclosed.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like